Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
The cultural mouse
2001 StandoutNobel
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
Cushing's syndrome
2015 Standout
Molecular basis of human hypertension: Role of angiotensinogen
1992 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The fetal insulin hypothesis: an alternative explanation of the association of low bir thweight with diabetes and vascular disease
1999
Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour
2001
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Forty years with homologous recombination
2001 StandoutNobel
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
2005
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension
2004
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Sgk1-Dependent Stimulation of Cardiac Na+/H+Exchanger Nhe1 by Dexamethasone
2013
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Male–female differences in fertility and blood pressure in ACE-deficient mice
1995 StandoutNatureNobel
Linkage of the Angiotensinogen Gene to Essential Hypertension
1994
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Obesity and cortisol
2000
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Quantification of topological changes in retinal vascular architecture in essential and malignant hypertension
2006
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
2009 StandoutNobel
Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol
2001
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Redox Signaling, Vascular Function, and Hypertension
2008
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro
2005 StandoutNobel
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
The angiotensin I converting enzyme gene and predisposition to high blood pressure.
1993
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
The anglo-scandinavian cardiac outcomes trial (ASCOT)
1998
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure
2001
Genetic Dissection of Complex Traits
1994 StandoutScience
Angiotensin-converting enzyme and male fertility
1998 StandoutNobel
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Angiotensinogen Gene Polymorphisms M235T/T174M
1999
High incidence of XXY and XYY males among the offspring of female chimeras from embryonic stem cells.
1995 StandoutNobel
Genetic control of blood pressure and the angiotensinogen locus.
1995 StandoutNobel
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.
1994 StandoutNobel
Uncompensated polyuria in a mouse model of Bartter's syndrome
2000 StandoutNobel
Plasma Angiotensin II, Predisposition to Hypertension, and Left Ventricular Size in Healthy Young Adults
1996
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
1996 StandoutNobel
Rarefaction of Skin Capillaries in Borderline Essential Hypertension Suggests an Early Structural Abnormality
1999
Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin II
1998 StandoutNobel
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of David Holton being referenced
Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure.
1997
Abnormalities of glucocorticoid metabolism and the renin???angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure
1992
Prediction of high blood pressure in young people
1991
Prediction of high blood pressure in young people
1991
Increased Glucocorticoid Activity in Men With Cardiovascular Risk Factors
1998